High FOXM1 expression was associated with bladder carcinogenesis
- PMID: 23325617
- DOI: 10.1007/s13277-013-0654-x
High FOXM1 expression was associated with bladder carcinogenesis
Abstract
The forkhead box M1 (FOXM1) transcription factor plays crucial roles in regulating the proliferation, differentiation, and transformation of cells. Overexpression of FOXM1 is associated with a variety of aggressive solid carcinomas, including bladder cancer. However, the precise role and molecular mechanism responsible for the aggressive action of FOXM1 in bladder cancer remain unclear. Real-time quantitative PCR, Western blot and immunohistochemistry were used to explore FoxM1 expression in bladder cancer cell lines, primary bladder cancer clinical specimens and normal bladder tissues. FoxM1 expression was knocked down by small interfering RNA (siRNA) in T24 cells; proliferation, migration and invasion were assayed. FoxM1 expression was up-regulated in the majority of the bladder cancer tissue specimens at both mRNA and protein levels. Immunohistochemistry analysis showed that FoxM1 expression was significantly correlated with TNM stage and histological grade, metastasis. Experimentally, we found that down-regulation of FoxM1 inhibited cell proliferation, migration and invasion. These results suggested that FOXM1 up-regulation was associated with poor prognosis in bladder cancer, and therefore it might act as a prognostic marker and a new potential target for bladder cancer treatment.
Similar articles
-
Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.Ann Surg Oncol. 2013 Mar;20(3):1035-43. doi: 10.1245/s10434-012-2680-0. Epub 2012 Oct 2. Ann Surg Oncol. 2013. PMID: 23054116
-
Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer.Clin Transl Oncol. 2016 May;18(5):527-32. doi: 10.1007/s12094-015-1400-1. Epub 2015 Sep 14. Clin Transl Oncol. 2016. PMID: 26370421
-
Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma.J Transl Med. 2012 Sep 24;10:200. doi: 10.1186/1479-5876-10-200. J Transl Med. 2012. PMID: 23006512 Free PMC article.
-
Signaling of miRNAs-FOXM1 in cancer and potential targeted therapy.Curr Drug Targets. 2013 Sep;14(10):1192-202. doi: 10.2174/13894501113149990192. Curr Drug Targets. 2013. PMID: 23834153 Free PMC article. Review.
-
A new target for proteasome inhibitors: FoxM1.Expert Opin Investig Drugs. 2010 Feb;19(2):235-42. doi: 10.1517/13543780903563364. Expert Opin Investig Drugs. 2010. PMID: 20074015 Free PMC article. Review.
Cited by
-
Downregulation of FoxM1 inhibits cell growth and migration and invasion in bladder cancer cells.Am J Transl Res. 2018 Feb 15;10(2):629-638. eCollection 2018. Am J Transl Res. 2018. PMID: 29511457 Free PMC article.
-
Forkhead box protein M1 predicts outcome in human osteosarcoma.Int J Clin Exp Med. 2015 Sep 15;8(9):15563-8. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26629049 Free PMC article.
-
FoxM1 is associated with metastasis in colorectal cancer through induction of the epithelial-mesenchymal transition.Oncol Lett. 2017 Dec;14(6):6553-6561. doi: 10.3892/ol.2017.7022. Epub 2017 Sep 21. Oncol Lett. 2017. PMID: 29163688 Free PMC article.
-
Emerging Biomarkers in Bladder Cancer Identified by Network Analysis of Transcriptomic Data.Front Oncol. 2018 Oct 12;8:450. doi: 10.3389/fonc.2018.00450. eCollection 2018. Front Oncol. 2018. PMID: 30370253 Free PMC article. Review.
-
Exploration of genetics commonness between bladder cancer and breast cancer based on a silcio analysis on disease subtypes.Technol Health Care. 2018;26(S1):361-377. doi: 10.3233/THC-174699. Technol Health Care. 2018. PMID: 29758961 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous